Put Options on INMD on 10/23/2023

InMode Ltd. (INMD) designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.  

The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.

It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. 

Shares have formed a bearish flag after company missed it's guidance and lowered it's revenue guidance for the year. Lower share prices are expected. The company reports of November 2nd.

Entry Point: $19.70

Trading Range: $19.274 to $48.25

Trade Buy 1 November $20.00 Put at $1.45 For a net debit of $1.45 Profit/Loss Analysis Breakeven at $18.55 Maximum profit is unbounded Maximum loss is ($145.00) at strike of $20.00 Closing Summary Sold 1 November $20.00 Put at $0.00

Position closed on 11/27/2023 at price of $0.00 with a -100.00% loss in 35 days.

Back to Portfolio